Our Story

Meet the highly merited team of internationally recognised experts within the vaccine industry

Read more

The Portfolio

Learn more about our vaccine candidates and their market potential

Read more

Bridging the Gap

Explore how we transform novel vaccines candidates into effective treatments of tomorrow

Read more

News

Flaggningsmeddelande i Eurocine Vaccines AB

Eurocine Vaccines meddelar idag att Flerie Invest AB har förvärvat aktier i bolaget och passerat flaggningsgränsen om 10 % av röster och kapital. Flerie Invest…

Disclosure notice in Eurocine Vaccines

Eurocine Vaccines hereby announces that Flerie Invest AB has acquired shares in the company and holds above 10 % of the shares in the company.…

Positiva resultat med Endocine™ och en vaccinkandidat mot COVID-19

Den första prekliniska studien, där adjuvansteknologin Endocine™ utvärderats med en vaccinkandidat mot COVID-19, visar positiva resultat.Read More

News archive

Calendar

BioJapan

Eurocine Vaccines will participate virtually at Asia’s Largest Partnering event. A whole host of universities and biotechs, almost every major Japanese & global pharmaceutical companiesRead…

Calendar